1
|
Xie SH, Wahlin K and Lagergren J: Cause of
death in patients diagnosed with esophageal cancer in Sweden: A
population-based study. Oncotarget. 8:51800–51809. 2017.PubMed/NCBI
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Wang M, Hao C, Ma Q, Song G, Ma S, Zhao D,
Zhao L, Li X and Wei W: DNA image cytometry test for primary
screening of esophageal cancer: A population-based multi-center
study in high-risk areas in China. Chin J Cancer Res. 28:404–412.
2016. View Article : Google Scholar : PubMed/NCBI
|
4
|
Sohda M and Kuwano H: Current status and
future prospects for esophageal cancer treatment. Ann Thorac
Cardiovasc Surg. 23:1–11. 2017. View Article : Google Scholar : PubMed/NCBI
|
5
|
Song G, Liu K, Yang X, Mu B, Yang J, He L,
Hu X, Li Q, Zhao Y, Cai X and Feng G: SATB1 plays an oncogenic role
in esophageal cancer by up-regulation of FN1 and PDGFRB.
Oncotarget. 8:17771–17784. 2017.PubMed/NCBI
|
6
|
Bertolino E, Reimund B, Wildt-Perinic D
and Clerc RG: A novel homeobox protein which recognizes a TGT core
and functionally interferes with a retinoid-responsive motif. J
Biol Chem. 270:31178–31188. 1995. View Article : Google Scholar : PubMed/NCBI
|
7
|
Gripp KW, Wotton D, Edwards MC, Roessler
E, Ades L, Meinecke P, Richieri-Costa A, Zackai EH, Massagué J,
Muenke M and Elledge SJ: Mutations in TGIF cause holoprosencephaly
and link NODAL signalling to human neural axis determination. Nat
Genet. 25:205–208. 2000. View
Article : Google Scholar : PubMed/NCBI
|
8
|
Wotton D, Lo RS, Lee S and Massagué J: A
Smad transcriptional corepressor. Cell. 97:29–39. 1999. View Article : Google Scholar : PubMed/NCBI
|
9
|
Zhang MZ, Ferrigno O, Wang Z, Ohnishi M,
Prunier C, Levy L, Razzaque M, Horne WC, Romero D, Tzivion G, et
al: TGIF governs a feed-forward network that empowers Wnt signaling
to drive mammary tumorigenesis. Cancer Cell. 27:547–560. 2015.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Wang Y, Pan T, Wang H, Li L, Li J, Zhang C
and Yang H: Silencing of TGIF attenuates the tumorigenicity of A549
cells in vitro and in vivo. Tumour Biol. 37:12725–12730. 2016.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Wang Y, Wang H, Gao H, Xu B, Zhai W, Li J
and Zhang C: Elevated expression of TGIF is involved in lung
carcinogenesis. Tumour Biol. 36:9223–9231. 2015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Xiang G, Yi Y, Weiwei H and Weiming W:
TGIF1 promoted the growth and migration of cancer cells in nonsmall
cell lung cancer. Tumour Biol. 36:9303–9310. 2015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Borlak J, Meier T, Halter R, Spanel R and
Spanel-Borowski K: Epidermal growth factor-induced hepatocellular
carcinoma: Gene expression profiles in precursor lesions, early
stage and solitary tumours. Oncogene. 24:1809–1819. 2005.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Liu ZM, Tseng HY, Tsai HW, Su FC and Huang
HS: Transforming growth factor β-interacting factor-induced
malignant progression of hepatocellular carcinoma cells depends on
superoxide production from Nox4. Free Radic Biol Med. 84:54–64.
2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Huang HS, Liu ZM, Chen PC, Tseng HY and
Yeh BW: TG-interacting factor-induced superoxide production from
NADPH oxidase contributes to the migration/invasion of urothelial
carcinoma. Free Radic Biol Med. 53:769–778. 2012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Yeh BW, Wu WJ, Li WM, Li CC, Huang CN,
Kang WY, Liu ZM and Huang HS: Overexpression of TG-interacting
factor is associated with worse prognosis in upper urinary tract
urothelial carcinoma. Am J Pathol. 181:1044–1055. 2012. View Article : Google Scholar : PubMed/NCBI
|
17
|
Hamid R and Brandt SJ: Transforming
growth-interacting factor (TGIF) regulates proliferation and
differentiation of human myeloid leukemia cells. Mol Oncol.
3:451–463. 2009. View Article : Google Scholar : PubMed/NCBI
|
18
|
Hamid R, Patterson J and Brandt SJ:
Genomic structure, alternative splicing and expression of
TG-interacting factor, in human myeloid leukemia blasts and cell
lines. Biochim Biophys Acta. 1779:347–355. 2008. View Article : Google Scholar : PubMed/NCBI
|
19
|
Willer A, Jakobsen JS, Ohlsson E, Rapin N,
Waage J, Billing M, Bullinger L, Karlsson S and Porse BT: TGIF1 is
a negative regulator of MLL-rearranged acute myeloid leukemia.
Leukemia. 29:1018–1031. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Libório TN, Ferreira EN, Xavier Aquino FC,
Carraro DM, Kowalski LP, Soares FA and Nunes FD: TGIF1 splicing
variant 8 is overexpressed in oral squamous cell carcinoma and is
related to pathologic and clinical behavior. Oral Surg Oral Med
Oral Pathol Oral Radiol. 116:614–625. 2013. View Article : Google Scholar : PubMed/NCBI
|
21
|
Matizonkas-Antonio LF, Libório TN, Xavier
Aquino FC, Silva-Valenzuela Md, Michaluarte-Júnior P and Nunes FD:
Detection of TGIF1 homeobox gene in oral squamous cell carcinoma
according to histologic grading. Oral Surg Oral Med Oral Pathol
Oral Radiol Endod. 111:218–224. 2011. View Article : Google Scholar : PubMed/NCBI
|
22
|
Nakakuki K, Imoto I, Pimkhaokham A, Fukuda
Y, Shimada Y, Imamura M, Amagasa T and Inazawa J: Novel targets for
the 18p11.3 amplification frequently observed in esophageal
squamous cell carcinomas. Carcinogenesis. 23:19–24. 2002.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Chan AS, Mowla SN, Arora P and Jat PS:
Tumour suppressors and cellular senescence. IUBMB Life. 66:812–822.
2012. View
Article : Google Scholar
|
24
|
López-Sáez JF, de la Torre C, Pincheira J
and Giménez-Martin G: Cell proliferation and cancer. Histol
Histopathol. 13:1197–1214. 1998.PubMed/NCBI
|
25
|
Reed SI, Bailly E, Dulic V, Hengst L,
Resnitzky D and Slingerland J: G1 control in mammalian cells. J
Cell Sci Suppl. 18:69–73. 1994. View Article : Google Scholar : PubMed/NCBI
|
26
|
Reed SI: Control of the G1/S transition.
Cancer Surv. 29:7–23. 1997.PubMed/NCBI
|
27
|
Sherr CJ: Mammalian G1 cyclins. Cell.
73:1059–1065. 1993. View Article : Google Scholar : PubMed/NCBI
|
28
|
Weinberg RA: The retinoblastoma protein
and cell cycle control. Cell. 81:323–330. 1995. View Article : Google Scholar : PubMed/NCBI
|
29
|
Zhang M, Linghu E, Zhan Q, He T, Cao B,
Brock MV, Herman JG, Xiang R and Guo M: Methylation of DACT2
accelerates esophageal cancer development by activating Wnt
signaling. Oncotarget. 7:17957–17969. 2016. View Article : Google Scholar : PubMed/NCBI
|
30
|
Ge C, Wu S, Wang W, Liu Z, Zhang J, Wang
Z, Li R, Zhang Z, Li Z, Dong S, et al: miR-942 promotes cancer stem
cell-like traits in esophageal squamous cell carcinoma through
activation of Wnt/β-catenin signalling pathway. Oncotarget.
6:10964–10977. 2015. View Article : Google Scholar : PubMed/NCBI
|
31
|
Deng F, Zhou K, Cui W, Liu D and Ma Y:
Clinicopathological significance of wnt/β-catenin signaling pathway
in esophageal squamous cell carcinoma. Int J Clin Exp Pathol.
8:3045–3053. 2015.PubMed/NCBI
|
32
|
Lv J, Cao XF, Ji L, Zhu B, Wang DD, Tao L
and Li SQ: Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1
with the prognosis of esophageal squamous cell carcinoma. Med
Oncol. 29:151–160. 2012. View Article : Google Scholar : PubMed/NCBI
|
33
|
Xu Y and Lu S: Regulation of
β-catenin-mediated esophageal cancer growth and invasion by
miR-214. Am J Transl Res. 7:2316–2325. 2015.PubMed/NCBI
|
34
|
Jia Z, Yang Y, Dengyan Z, Chunyang Z,
Donglei L, Kai W and Song Z: RAP1B, a DVL2 binding protein,
activates Wnt/beta-catenin signaling in esophageal squamous cell
carcinoma. Gene. 611:15–20. 2017. View Article : Google Scholar : PubMed/NCBI
|
35
|
Henkels KM and Turchi JJ:
Cisplatin-induced apoptosis proceeds by caspase-3-dependent and
-independent pathways in cisplatin-resistant and -sensitive human
ovarian cancer cell lines. Cancer Res. 59:3077–3083.
1999.PubMed/NCBI
|
36
|
Horky M, Wurzer G, Kotala V, Anton M,
Vojtĕsek B, Vácha J and Wesierska-Gadek J: Segregation of nucleolar
components coincides with caspase-3 activation in cisplatin-treated
HeLa cells. J Cell Sci. 114:663–670. 2001.PubMed/NCBI
|
37
|
Rheaume E, Cohen LY, Uhlmann F, Lazure C,
Alam A, Hurwitz J, Sekaly RP and Denis F: The large subunit of
replication factor C is a substrate for caspase-3 in vitro and is
cleaved by a caspase-3-like protease during Fas-mediated apoptosis.
EMBO J. 16:6346–6354. 1997. View Article : Google Scholar : PubMed/NCBI
|
38
|
Liu ZM, Tseng JT, Hong DY and Huang HS:
Suppression of TG-interacting factor sensitizes arsenic
trioxide-induced apoptosis in human hepatocellular carcinoma cells.
Biochem J. 438:349–358. 2011. View Article : Google Scholar : PubMed/NCBI
|